Medbase ads

💊 What does medication safety look like in highly specialised hospital care? At Hannover Medical School (MHH), the Central Pharmacy works closely with physicians and nursing staff to support safe and effective medication therapy – often in situations involving complex medication regimens that change throughout a patient’s hospital stay. Medbase Portal, our browser-based medication safety platform, supports the Central Pharmacy team in their daily work by bringing relevant information on medication-related risks, interactions and dosing considerations into one structured view. One feature in particular stands out for the team: “The integrated alternative finder for targeted problem-solving and medication optimisation is unique.” – Dr. rer. nat. Dipl.-Pharm. Stefan Biastoff, Hannover Medical School A big thank you to the MHH Central Pharmacy team for sharing their experience and giving us a glimpse into their daily work 💚 👉 Read the full customer story via the link in the comments. #MedicationSafety #ClinicalPharmacy #ClinicalDecisionSupport #MedbasePortal #Medbase

💊 How do clinical pharmacists manage increasingly complex medication therapies? Our latest customer story highlights how Klinikum Oldenburg AöR uses Medbase Portal to support pharmaceutical validation, medication reviews, ward rounds, and Closed Loop Medication Management. With a team of around 70 pharmacy professionals, the hospital pharmacy works closely with physicians and nurses to optimise medication therapy and support safe medication use. 💻 In their everyday clinical pharmacy work and medication reviews, the team relies on Medbase Portal. The browser-based platform provides access to evidence-based medication information in German, helping the team assess polypharmacy and complex treatment combinations. As Kim Green, Head of Hospital Pharmacy at Klinikum Oldenburg, explains: "The medication information provided by Medbase is highly valued in our daily clinical work. The structured and intuitive presentation of complex information enables fast and well-informed clinical decision-making." 👉 Read the full customer story: https://lnkd.in/dnv3RNRa #MedicationSafety #ClinicalPharmacy #HospitalPharmacy #MedicationManagement #Medbase #CustomerStory

Meet Päivi 👋 Behind every trusted healthcare solution, there is a great deal of work that users never see. As Medbase's Director of Quality and Regulatory Compliance, Päivi Turta helps ensure that quality, safety and compliance are built into everything we develop. It is work that requires precision, collaboration and continuous improvement – all with one important purpose: supporting patient safety. One of the recent milestones has been the certification and launch of Medbase CDS, a journey that has given Päivi the opportunity to see years of quality and compliance work turn into something tangible. “Quality and regulatory work is ultimately about trust. In healthcare solutions, reliability and safety are essential." In our latest We Are Medbase story, Päivi shares what quality and regulatory compliance really means in practice and why it matters for healthcare professionals and patient safety. 👉 Read Päivi's story: https://lnkd.in/dSinJVeP #WeAreMedbase #MDR #Medbase #ClinicalDecisionSupport #MedbaseCDS

Meet Jori 👋 As part of our medical team, Jori combines his work at Medbase with clinical practice as a neurologist at Turku University Hospital (TYKS) and research, particularly in the field of stroke. In our latest We Are Medbase story, Jori shares how these different perspectives complement each other – and why there is always something new to learn in medicine. And yes, you’ll also meet Fanni, his occasional four-legged office companion 🐾 👉 Meet Jori and read his story https://lnkd.in/dp2AVKnf #WeAreMedbase #Medbase #MedicationSafety #SPOCK

🔎 Strong evidence. Effective treatments. Why are so many patients still missing out? 🔹 A US study involving nearly 7 million patients with type 2 diabetes and cardiovascular and/or kidney disease found that 80% of those eligible for guideline-directed cardiorenal protective treatment lacked a current prescription. 🔹 European findings point to a similar gap – and show that chronic kidney disease often remains unrecognised. Earlier recognition and systematic assessment of treatment eligibility could help bring the benefits of clinical evidence into everyday care. Our latest Science to Practice article looks at the findings and their implications for kidney and cardiovascular health. Read more ➡️ https://lnkd.in/drEBhNzE #ScienceToPractice #KidneyHealth #ClinicalPractice #Medbase

⚖️How confident can we be about drug dosing in liver cirrhosis? New research points to considerable uncertainty – particularly as liver disease becomes more severe. In a multidisciplinary expert evaluation: 🔹 Consensus was reached for only 20% of 177 recommendations 🔹 Agreement fell from 83% in Child-Pugh A to 47% in B and 41% in C 🔹 Even where consensus was reached, only half of the recommendations were fully consistent with the corresponding Summary of Product Characteristics The findings highlight the need for clearer, harmonised and stage-specific dosing guidance for patients with liver cirrhosis. Read more in our latest Science to Practice article ➡️ https://lnkd.in/eEJ3vyDP #ScienceToPractice #DrugSafety #ClinicalPharmacology #LiverCirrhosis